Description: Developing and marketing neurology, oncology, and psychiatry products wordwide. The principle product is Xenazine 25TM (tetrabenazine) indicated for hyperkinetic movement disorders and tardive dyskinesia. Site also features company profile and news, and a link list to other resources related.